XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Expenses        
Research and development $ 2,792 $ 5,243 $ 11,684 $ 13,715
Selling, general and administrative 2,388 1,676 8,642 5,568
Depreciation 222 230 680 717
Restructuring charges (Note 8) 0 354 744 1,847
Total expenses 5,402 7,503 21,750 21,847
Operating loss (5,402) (7,503) (21,750) (21,847)
Investment and other (expenses) income        
Net foreign exchange losses 0 (54) (74) (36)
Interest income 27 39 80 175
Fair value change in contingent consideration (Note 3) 0 71 1,466 1,904
Other 17 64 115 100
Total investment and other income 44 120 1,587 2,143
Loss from continuing operations before income taxes (5,358) (7,383) (20,163) (19,704)
Recovery of (provision for) income taxes (Note 9) 432 (109) 194 (434)
Loss from continuing operations (4,926) (7,492) (19,969) (20,138)
(Loss) income from discontinued operations, net of income taxes (Note 10) (6) 96 (63) 116
Net loss and comprehensive loss $ (4,932) $ (7,396) $ (20,032) $ (20,022)
Basic and diluted net loss per common share (Note 12)        
Continuing operations $ (0.10) $ (0.15) $ (0.39) $ (0.40)
Discontinued operations $ 0.00 $ 0.00 $ 0.00 $ 0.00
Net loss per common share $ (0.10) $ (0.14) $ (0.39) $ (0.39)
Weighted average number of common shares outstanding        
Basic and diluted 51,151 51,082 51,105 50,851